Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 3 minute read Pharma Industry News Cognition Therapeutics reports promising Phase 2 results for CT1812 in dementia with Lewy bodies Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage pharmaceutical company focused on neurodegenerative disorder treatment, has reported highly encouraging… byPallavi MadhirajuDecember 18, 2024